The future of cancer immunotherapy with Elicio Therapeutics
Drug Target Review
MARCH 1, 2024
This antigen-spreading is critical to long-term protection because tumour often develop with inconsistent antigen expression – equipping the immune response to target many diverse tumour antigens may allow for more complete anti-tumour activity. Dr Haqq holds multiple patents and publications.
Let's personalize your content